BioSig Technologies, Inc. (BSGM)
BSGM Stock Price Chart
Explore BioSig Technologies, Inc. interactive price chart. Choose custom timeframes to analyze BSGM price movements and trends.
BSGM Company Profile
Discover essential business fundamentals and corporate details for BioSig Technologies, Inc. (BSGM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
31 Oct 2014
Employees
5.00
Website
https://www.biosig.comCEO
Anthony Amato
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BSGM Financial Timeline
Browse a chronological timeline of BioSig Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.04.
Earnings released on 15 Aug 2025
EPS came in at -$0.74 falling short of the estimated -$0.04 by -1.75K%.
Earnings released on 19 May 2025
EPS came in at -$0.14 falling short of the estimated -$0.05 by -180.00%.
Earnings released on 15 Apr 2025
EPS came in at -$0.03 surpassing the estimated -$0.17 by +82.35%, while revenue for the quarter reached $13.00K .
Earnings released on 14 Nov 2024
EPS came in at -$0.12 surpassing the estimated -$0.20 by +40.00%.
Earnings released on 14 Aug 2024
EPS came in at -$0.30 falling short of the estimated -$0.10 by -200.00%, while revenue for the quarter reached $13.00K .
Earnings released on 20 May 2024
EPS came in at -$0.36 falling short of the estimated -$0.29 by -24.14%, while revenue for the quarter reached $14.00K .
Earnings released on 16 Apr 2024
EPS came in at -$0.82 falling short of the estimated -$0.50 by -64.00%, while revenue for the quarter reached $12.00K , missing expectations by -88.00%.
Stock split effective on 2 Feb 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2023
EPS came in at -$0.60 falling short of the estimated -$0.10 by -500.00%, while revenue for the quarter reached $1.00K , missing expectations by -99.00%.
Earnings released on 14 Aug 2023
EPS came in at -$1.60 falling short of the estimated -$0.10 by -1.50K%.
Earnings released on 15 May 2023
EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%, while revenue for the quarter reached $5.00K , missing expectations by -97.04%.
Earnings released on 31 Mar 2023
EPS came in at -$1.40 falling short of the estimated -$0.12 by -1.07K%, while revenue for the quarter reached $135.00K , missing expectations by -25.62%.
Earnings released on 14 Nov 2022
EPS came in at -$1.40 matching the estimated -$1.40, while revenue for the quarter reached $135.00K , missing expectations by -68.94%.
Earnings released on 15 Aug 2022
EPS came in at -$1.50 surpassing the estimated -$1.70 by +11.76%, while revenue for the quarter reached $8.00K , missing expectations by -86.09%.
Earnings released on 16 May 2022
EPS came in at -$0.22 falling short of the estimated -$0.18 by -22.22%, while revenue for the quarter reached $8.00K , missing expectations by -98.96%.
Earnings released on 31 Mar 2022
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%, while revenue for the quarter reached $8.00K , missing expectations by -97.27%.
Earnings released on 15 Nov 2021
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%, while revenue for the quarter reached $108.00K , missing expectations by -58.46%.
Earnings released on 11 Aug 2021
EPS came in at -$2.40 falling short of the estimated -$0.26 by -823.08%, while revenue for the quarter reached $207.00K , missing expectations by -26.07%.
Earnings released on 17 May 2021
EPS came in at -$2.60 falling short of the estimated -$0.15 by -1.63K%, while revenue for the quarter reached $118.00K , beating expectations by +1.01%.
Earnings released on 15 Mar 2021
EPS came in at -$3.10 falling short of the estimated -$0.43 by -620.93%.
Earnings released on 5 Nov 2020
EPS came in at -$3.80 falling short of the estimated -$0.45 by -744.44%.
BSGM Stock Performance
Access detailed BSGM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.